Alnylam Pharmaceuticals shares owned by Monograph Wealth Advisors
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Monograph Wealth Advisors
from 13F filings
Historical chart of Monograph Wealth Advisors investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Monograph Wealth Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Monograph Wealth Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $409k | 2.1k | 191.41 |
| 2023-09-30 | $377k | 2.1k | 177.10 |
| 2023-06-30 | $404k | 2.1k | 189.94 |
| 2023-03-31 | $426k | 2.1k | 200.32 |
| 2022-12-31 | $509k | 2.1k | 237.63 |
| 2022-09-30 | $426k | 2.1k | 200.38 |
| 2022-06-30 | $310k | 2.1k | 145.81 |
| 2022-03-31 | $348k | 2.1k | 163.07 |
| 2021-12-31 | $362k | 2.1k | 169.63 |